01025814

Component

http://onlinepubs.trb.org...nepubs/circulars/ec096.pdf

It seems difficult to base regulations for medicinal drugs on epidemiological data due to the important number of substances involved. Only the benzodiazepines (BZDs) have shown a sufficient effect on driving ability to induce statistical evidences. The recommendations concerning all the medicinal drugs should be based on a categorization of medicines regarding their effects on driving ability and behavior. The pharmacological classification can be based only on the effects of substances, but regulations also must be based on doses, way of use, and therapeutic indications. The classification introduced in France is based on a three-level warning, with a triangle including a car, printed on the box. Such a system allows to take into account not only the simple pharmacological effect of the substance, but also all other facts concerning the medicinal drug.

Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the Transportation Research Board of the National Academy of Sciences. Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Copyright © National Academy of Sciences. All rights reserved

01025806

English

p 78

2006-5

Transportation Research Circular

Drugs and Traffic: A Symposium

Web

Classification; Drugged drivers; Drugs; Medication; Pharmacology; Regulations

Benzodiazepines

France

Highways; Law; Safety and Human Factors; I83: Accidents and the Human Factor

TRIS, TRB

Jun 21 2006 1:13PM

• Commentary on Cannabis and Crash Risk: Concentration Effect Relation
• Commentary on History of DWI Enforcement: What Does It Tell Us About DUID Enforcement?
• Commentary on Legal Framework for Dealing with Drugs in Traffic
• Commentary on Legal Framework for Dealing with Drugs in Traffic
• Commentary on Medicinal Drugs: Critical Review of Present Knowledge and Statements for Discussion
• Commentary on the Risks Posed by Drugs in Traffic
• Commentary on the Risks Posed by Drugs in Traffic
• Commentary on Variability Among Epidemiological Studies of Drugs and Driving
• Drug Effects and Their Significance for Traffic Safety
• Drug-Impaired Driving: Improving Integration of Toxicology, Technology, and Enforcement
• Drugs and Traffic: A Symposium. Overview and Summary
• European Union Research Project IMMORTAL: The Risk of Drink and Drug Driving—Results of a Case-Control Study Conducted in the Netherlands
• Legal Framework for Dealing with Drugs in Traffic
• Medicinal Drugs: Critical Review of Present Knowledge and Statements for Discussion
• Role of Cannabis and Benzodiazepines in Motor Vehicle Crashes